Health Insurer Humana Sues Maker Of Eylea Eye Drug For Secretly Funding Co-Pays

(August 2, 2021, 11:43 AM EDT) -- NEW YORK — Health insurer Humana Inc. on July 22 filed a civil complaint against Regeneron Pharmaceuticals Inc., alleging that the maker of the macular degeneration drug Eylea cost the insurer more than $900 million by secretly funding drug co-pays through a charity....

Attached Documents

Related Sections